Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
Atavistik Bio, Inc
NiKang Therapeutics, Inc.
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Eli Lilly and Company
AstraZeneca
BeOne Medicines
ViroMissile, Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Incyte Corporation
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
Cogent Biosciences, Inc.
SystImmune Inc.
SN BioScience
Orano Med LLC
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
Fusion Pharmaceuticals Inc.
OncoNano Medicine, Inc.
National Institutes of Health Clinical Center (CC)
MOMA Therapeutics
Risen (Suzhou) Pharma Tech Co., Ltd.
GlaxoSmithKline
Fate Therapeutics
NextCure, Inc.
SystImmune Inc.
Mersana Therapeutics
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
EtiraRx Australia Pty Ltd
Exelixis
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
GONGCHU Biotechnology Co., Ltd
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center
First Affiliated Hospital of Zhejiang University
Sichuan Enray Pharmaceutical Sciences Company
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Novita Pharmaceuticals, Inc.
University of Virginia
University of Colorado, Denver